Mechanistic differentiation of thyrotoxicosis, including Graves disease, thyroiditis, and exogenous hormone exposure.
Thyrotoxicosis refers to the clinical state of excess thyroid hormone action, while hyperthyroidism specifically denotes increased hormone synthesis by the thyroid gland. Differentiating mechanism guides treatment. Graves disease is the prototypical hyperthyroid state, driven by TSH receptor antibodies that stimulate hormone synthesis and gland growth. Patients may have diffuse goiter, ophthalmopathy, and elevated thyroid-stimulating immunoglobulins. In contrast, thyroiditis (subacute, painless, postpartum) causes release of preformed hormone due to follicular injury; synthesis is not increased. As a result, antithyroid drugs are ineffective in thyroiditis, whereas symptomatic control with beta-blockers is often sufficient until the hyperthyroid phase resolves.
Biochemical evaluation typically shows suppressed TSH with elevated free T4 and/or free T3. A disproportionately high T3 (T3 toxicosis) can occur early in Graves. Uptake studies, where available, are especially helpful: diffuse elevated uptake suggests Graves, focal uptake suggests toxic adenoma, and low uptake suggests thyroiditis or exogenous hormone. Thyroglobulin can help distinguish endogenous hormone release from factitious thyrotoxicosis, which often features low thyroglobulin and low uptake.
Clinical context matters. Recent pregnancy supports postpartum thyroiditis; neck pain and elevated inflammatory markers suggest subacute thyroiditis. Iodine load or amiodarone can precipitate thyrotoxicosis through distinct mechanisms, requiring specialized management. A mechanism-first framework avoids misapplication of antithyroid therapy and supports timely referral when severe disease, atrial fibrillation, or thyroid storm risk is present.
Biochemical evaluation typically shows suppressed TSH with elevated free T4 and/or free T3. A disproportionately high T3 (T3 toxicosis) can occur early in Graves. Uptake studies, where available, are especially helpful: diffuse elevated uptake suggests Graves, focal uptake suggests toxic adenoma, and low uptake suggests thyroiditis or exogenous hormone. Thyroglobulin can help distinguish endogenous hormone release from factitious thyrotoxicosis, which often features low thyroglobulin and low uptake.
Clinical context matters. Recent pregnancy supports postpartum thyroiditis; neck pain and elevated inflammatory markers suggest subacute thyroiditis. Iodine load or amiodarone can precipitate thyrotoxicosis through distinct mechanisms, requiring specialized management. A mechanism-first framework avoids misapplication of antithyroid therapy and supports timely referral when severe disease, atrial fibrillation, or thyroid storm risk is present.
Published March 4, 2026